glow gummies tandem diabetes care
Two brands. One shared mission.
Adhesive sleeve sold separately.
Adhesive sleeve sold separately.
This sweet collab between Tandem Diabetes Care and Glow Gummies celebrates you.
In honor of National Diabetes Awareness Month, we’re coming together to bring you an inspired take with all of Tandem and Glow’s best qualities.
Delicious and soft, our fast-acting gummies are packed with flavor and clean ingredients to make your management easier and more enjoyable. No chalky textures, synthetic dyes, or slow-to-act ingredients.
Celebrate National Diabetes Awareness Month with this limited edition flavor that packs a punch - just like you.
WHY YOU'LL LOVE BLUE RASPBERRY
- Designed to work fast
- 4 gummies = 15 g carbs
- Clean ingredients — no artificial dyes or corn syrup
- Deliciously balanced flavor
- Portable + discrete – just like the Tandem Mobi
CELEBRATING
NATIONAL DIABETES
AWARENESS MONTH
TOGETHER
Raising awareness (and blood
sugars) has never been so sweet.
Together, we’re bringing you another
delicious and empowering choice to
celebrate our diabetes community.
YOUR NEW FAVORITE FLAVOR
IS HERE
Stock up before it's gone — limited edition for NDAM.
Important Safety Information: RX ONLY. The Tandem Mobi insulin pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. Tandem Mobi system: The Tandem Mobi insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Tandem logos, Control-IQ+, and Tandem Mobi are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. All third-party marks are the property of their respective owners.